Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Global Health

Marsh McLennan Advantage

High-income countries have, on average, administered nearly 25 times more doses of coronavirus vaccines than low-income countries.

Healthcare remains a high-profile target for cyberattacks. Following Russia’s invasion of Ukraine, providers across the globe are on high alert.

Principal, Oliver Wyman
Principal, Digital and Health and Life Sciences, Oliver Wyman

The 2022 Global Risks Report — prepared by the World Economic Forum with the support of Marsh McLennan and other partners — examines conflicting response strategies to the pandemic.

Risk Management Leader for Continental Europe, Marsh

Pharmaceutical giants are shedding business units with an eye toward focusing on their innovative pharma operations and targeted therapeutic areas.

Head of UK and Ireland Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

And How Stakeholders Can, Literally, Save the World

Climate change will be the biggest impact on global health. The healthcare industry may not respond in time.

Director, Marsh & McLennan Advantage Insights
Partner, Health and Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe

Featured in the Middle East Insurance Review

COVID-19 sparked health system disruption in the Middle East. Here are some emerging digital health trends and mid-term insurer implications.

Partner, Health and Life Sciences, Oliver Wyman

Why closing the loop and creating a virtuous health promotion cycle will transform "sick care" to "well-care."

Partner, Health and Life Sciences, Oliver Wyman
Associate, Oliver Wyman

The distribution of COVID-19 vaccines like Moderna, Pfizer, and others demands immediate supply chain analysis and preparation.

Partner, Oliver Wyman
Partner, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

Asia Health Ecosystem Series, Volume II - Part 1

We explore the amplification of primary care and how it's evolving into something new.

Principal, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Consultant, Oliver Wyman

How the rapid reinvention of care presents the opportune time for Asia's providers to align their portfolios.

Partner, Health and Life Sciences, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman
Manager, Health & Life Sciences, Oliver Wyman
Partner and Head of Digital, Asia Pacific, Oliver Wyman
Engagement Manager, Digital, Asia Pacific, Oliver Wyman

Insights in your inbox

Subscribe